Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$11.09
-1.5%
$9.98
$5.84
$13.50
$458.52M0.78608,754 shs51,465 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$14.56
+0.4%
$14.21
$11.06
$27.13
$1.14B1.211.05 million shs54,029 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$14.15
-0.1%
$14.05
$10.24
$20.73
$558.98M0.89333,062 shs11,403 shs
Surmodics, Inc. stock logo
SRDX
Surmodics
$28.92
+0.8%
$33.84
$26.00
$40.38
$413.56M1.31186,391 shs15,227 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-3.26%+4.84%+4.94%+22.66%+84.59%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-2.03%+6.38%-9.32%+11.54%-14.71%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-3.01%-1.32%-2.61%+25.29%-7.33%
Surmodics, Inc. stock logo
SRDX
Surmodics
-1.44%-4.05%-11.37%-4.37%-25.30%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$11.09
-1.5%
$9.98
$5.84
$13.50
$458.52M0.78608,754 shs51,465 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$14.56
+0.4%
$14.21
$11.06
$27.13
$1.14B1.211.05 million shs54,029 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$14.15
-0.1%
$14.05
$10.24
$20.73
$558.98M0.89333,062 shs11,403 shs
Surmodics, Inc. stock logo
SRDX
Surmodics
$28.92
+0.8%
$33.84
$26.00
$40.38
$413.56M1.31186,391 shs15,227 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-3.26%+4.84%+4.94%+22.66%+84.59%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-2.03%+6.38%-9.32%+11.54%-14.71%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-3.01%-1.32%-2.61%+25.29%-7.33%
Surmodics, Inc. stock logo
SRDX
Surmodics
-1.44%-4.05%-11.37%-4.37%-25.30%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
2.50
Moderate Buy$19.3374.30% Upside
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.75
Reduce$18.5027.10% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.50
Moderate Buy$21.7553.71% Upside
Surmodics, Inc. stock logo
SRDX
Surmodics
2.00
Hold$43.0048.69% Upside

Current Analyst Ratings Breakdown

Latest SRDX, IART, OFIX, and ANGO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2025
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell
10/3/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $18.00
9/27/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/27/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Surmodics, Inc. stock logo
SRDX
Surmodics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/23/2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$17.00
8/12/2025
Surmodics, Inc. stock logo
SRDX
Surmodics
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/11/2025
Surmodics, Inc. stock logo
SRDX
Surmodics
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
7/16/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$24.00
7/16/2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$16.00
(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$292.50M1.56$0.46 per share23.90$4.51 per share2.46
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$1.61B0.70$4.37 per share3.33$20.03 per share0.73
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$799.49M0.70N/AN/A$13.07 per share1.08
Surmodics, Inc. stock logo
SRDX
Surmodics
$126.08M3.28$0.31 per share94.12$8.33 per share3.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$33.99M-$0.78N/AN/AN/A-10.67%-3.16%-2.07%N/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-$6.94M-$6.53N/A5.82N/A-30.87%12.15%4.32%11/3/2025 (Estimated)
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$126M-$3.17N/AN/AN/A-15.29%-25.43%-14.46%11/6/2025 (Estimated)
Surmodics, Inc. stock logo
SRDX
Surmodics
-$11.54M-$1.23N/A36.15N/A-14.59%-2.99%-1.99%11/5/2025 (Estimated)

Latest SRDX, IART, OFIX, and ANGO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2025Q3 2025
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.46N/AN/AN/AN/AN/A
10/2/2025Q1 2026
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.12-$0.10+$0.02-$0.26$72.69 million$75.71 million
8/8/2025Q3 2025
Surmodics, Inc. stock logo
SRDX
Surmodics
-$0.21$0.06+$0.27-$0.37$28.04 million$29.57 million
8/5/2025Q2 2025
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$0.04-$0.36-$0.40-$0.36$196.89 million$203.12 million
7/31/2025Q2 2025
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.43$0.45+$0.02-$6.31$395.06 million$415.61 million
7/15/2025Q4 2025
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.12-$0.03+$0.09-$0.15$74.26 million$80.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A
Surmodics, Inc. stock logo
SRDX
Surmodics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.29
1.38
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.18
1.23
0.73
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.38
2.67
1.50
Surmodics, Inc. stock logo
SRDX
Surmodics
0.27
3.91
3.10

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
84.78%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%
Surmodics, Inc. stock logo
SRDX
Surmodics
96.63%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
6.00%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
3.54%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1.30%
Surmodics, Inc. stock logo
SRDX
Surmodics
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
76041.20 million38.73 millionOptionable
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4,39677.91 million75.15 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,61639.49 million38.98 millionOptionable
Surmodics, Inc. stock logo
SRDX
Surmodics
45014.30 million13.03 millionOptionable

Recent News About These Companies

What's Next: Surmodics's Earnings Preview
Surmodics (SRDX) Q3 EPS Turns Positive

New MarketBeat Followers Over Time

Media Sentiment Over Time

AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$11.09 -0.17 (-1.49%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$14.56 +0.06 (+0.38%)
As of 10:27 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Orthofix Medical stock logo

Orthofix Medical NASDAQ:OFIX

$14.15 -0.02 (-0.14%)
As of 10:27 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Surmodics stock logo

Surmodics NASDAQ:SRDX

$28.92 +0.22 (+0.77%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.